Prof. Dr. Matthias Beckmann



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer (2024) Tempfer C, Fehm T, Vordermark D, Marnitz-Schulze S, Beckmann M, Denschlag D, Brucker S, et al. Journal article A content-based review of mobile health applications for breast cancer prevention and education: Characteristics, quality and functionality analysis (2024) Altmannshofer S, Flaucher M, Beierlein M, Eskofier B, Beckmann M, Fasching P, Hübner H Journal article, Review article Survival and hormone production of isolated mouse follicles in three-dimensional artificial scaffolds after stimulation with bpV(HOpic) (2024) Keckstein P, Dittrich R, Bleisinger N, Hoffmann I, Beckmann M, Gebhardt A, Schmid B, Keckstein S Journal article Influence of basic knowledge about female health, physiology, and contraception on unintended pregnancies: an international multicenter survey among women in Austria, Germany and Switzerland (2024) Allerstorfer C, Reiter E, Shebl O, Oppelt P, Reid AM, Schimetta W, Binder H, Beckmann M Journal article Medikamentöse Therapie der Endometriose (2024) Burghaus S, Beckmann M Journal article, Review article Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer (2024) Heger L, Heidkamp GF, Amon L, Nimmerjahn F, Bäuerle T, Maier A, Erber R, et al. Journal article Comparative assessment of breast volume using a smartphone device versus MRI (2024) Behrens A, Hübner H, Häberle L, Stamminger M, Zint D, Heindl F, Emons J, et al. Journal article Impact of CCND1 amplification on the prognosis of hormone receptor–positive, HER2-negative breast cancer patients—correlation of clinical and pathological markers (2024) Hanf D, Fasching P, Gaß P, Beckmann M, Hack C, Heindl F, Häberle L, et al. Journal article Bedeutung der parametrischen und molekularen Bildgebung für das therapeutische Management des Mammakarzinoms (2024) Hack C, Wetzl M, Schmidt D, Beckmann M Journal article Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center. (2023) Tögel L, Schubart C, Lettmaier S, Neufert C, Hoyer J, Wolff K, Moskalev E, et al. Journal article